Evidence map›Paper›PMID 41884009›Full record

ArticleTherapeutic advances in musculoskeletal disease2026

Consensus statements on the transition care for adolescents with rheumatic diseases in Saudi Arabia.

Mohammed Nashawi, Hana Alahmari, Emtenan Basahl, Toka Alsulaim, Arwa Alhamed, Aisha Mirza, Waleed Hafiz, Deyaa Mukhtar, Abdullah Aljaser, Hanan Al Rayes and 16 more

Abstract read
In one paragraph

Article in Therapeutic advances in musculoskeletal disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Mohammed NashawiFaculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.ORCID https://orcid.org/0000-0001-7580-2655
Hana AlahmariDivision of Rheumatology, Department of Medicine, King Khalid University, Abha, Saudi Arabia.
Emtenan BasahlDepartment of Pediatrics, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Toka AlsulaimRheumatology Division, Department of Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Arwa AlhamedCollege of Nursing, King Saud Bin Abdulaziz for Health Sciences, Riyadh, Saudi Arabia.
Aisha MirzaDepartment of Pediatrics, Maternity and Children Hospital, Makkah Health Cluster, Makkah, Saudi Arabia.
Waleed HafizDepartment of Medicine, College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
Deyaa MukhtarAdult Rheumatology, Department of Medicine, King Abdulaziz Hospital, Makkah, Saudi Arabia.
Abdullah AljaserPediatric Rheumatology Unit, Department of Pediatrics, Abha Maternity and Children Hospital, Abha, Saudi Arabia.
Hanan Al RayesRheumatology Unit, Department of Medicine, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Hamza AlbaderRheumatology Department, King Fahad Hospital, Ministry of Health, Madinah, Saudi Arabia.
Jubran AlqanatishDepartment of Pediatric Rheumatology, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Khairiyah AlsufyaniDepartment of Pediatrics, Maternity and Children Hospital, Makkah Health Cluster, Makkah, Saudi Arabia.
Khaled AlderaanRheumatology, Department of Medicine, King Fahad Specialist Hospital-Dammam, Dammam, Saudi Arabia.
Mahmoud MajeedDepartment of Pediatrics, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia.
Mansour SomailyRheumatology Division, Department of Medicine, Armed Forces Hospital-Southern Region, Khamis Mushait, Saudi Arabia.
Mohmmad AltowijryDepartment of Pediatrics, King Salman Armed Forces Hospital in Northwestern Region, Tabuk, Saudi Arabia.
Mohammed AttarDepartment of Rheumatology, Al Hada Armed Forces Hospital, Al Hada, Saudi Arabia.
Mohammed OlfatDivision of Pediatric Rheumatology, Maternity and Children Hospital, Madinah, Saudi Arabia.
Mohammed A OmairRheumatology Unit, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Mutibah AlessiDepartment of Pediatrics, King Fahad Hospital of the University, Al-Khobar, Saudi Arabia.
Sulaiman M Al-MayoufDepartment of Pediatrics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Zeyad AlzahraniDepartment of Rheumatology, Ministry of National Guard Health Affairs, King Abdulaziz Medical City, Jeddah, Saudi Arabia.
Nayef Al GhanimRheumatology, King Saud Medical City, Riyadh, Saudi Arabia.
Abdulaziz AlmutairiDepartment of Pediatric Rheumatology, King Saud Medical City, Riyadh, Saudi Arabia.
Wafaa AlsuwairiDepartment of Pediatric Rheumatology, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Rheumatic and musculoskeletal disorders (RMDs) of childhood onset are chronic conditions that often persist into adulthood, necessitating a structured transition from Pediatric to adult healthcare. In Saudi Arabia, no standardized protocol exists, leading to inconsistencies and care gaps for adolescents with RMDs. Saudi health transformation goals include improving overall health, enhancing the quality and accessibility of healthcare services, and increasing value by improving outcomes and controlling costs. Objective: To develop a consensus statement on transitional care for adolescents with juvenile autoimmune diseases in Saudi Arabia, providing a structured framework to guide healthcare providers in creating effective transition programs. Design: We used the Delphi methodology, integrating a literature review with expert opinions to generate consensus statements. Methods: A steering committee oversaw the process, which involved two rounds of voting among 16 expert panelists. Consensus was defined as >75% of participants' agreement. Statements that did not achieve consensus were revised and subjected to a second round of evaluation. The consensus was reviewed and supported by two adolescent patients. Results: In the first round, consensus was reached on 21 of 30 statements; 9 were revised for the second round, and 3 additional statements were introduced. Of these 12 second-round statements, 7 reached consensus. Key findings included establishing a structured national transition protocol, ongoing professional development for healthcare providers, and educational programs for patients and their families. The study also highlighted the necessity of regular readiness assessments using validated tools, such as the Transition Readiness Assessment Questionnaire, and the importance of a multidisciplinary approach to transition care. Conclusion: The consensus statement provides a foundational framework for transitional care in Saudi Arabia, addressing the need for structured, patient-centered transition programs. Clear guidelines, continuous assessment, education, and multidisciplinary collaboration are emphasized to improve care quality and outcomes for adolescents with RMDs transitioning to adult healthcare.

Indexed as

consensusmusculoskeletal disordersrheumatic diseaseSaudi Arabiatransition

Identifiers

PMID41884009
PMCPMC13009936

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.